Cooperative Agreement U01EB034222
Award Date
8/1/24
Completion Date
5/31/29
Dollars Obligated
$2.8M
Federal Agency
National Institute of Biomedical Imaging and Bioenginering
Federal Grant Program
93.286
Assistance Type
Cooperative Agreement
Place of Performance
Seattle, WA 98195, USA
Similar Awards
The federal Project Grant award R01EB035144, funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), will develop a novel molecular imaging technology that combines positron emission tomography (PET) and ultrasound (US) imaging. The $1,541,316 award, with a period of performance from Sep 1, 2024 to May 31, 2028, aims to create a compact PET device with a...
The University of Wisconsin-Madison received a $576,756 Project Grant award from the National Institutes of Health's Research Infrastructure Programs (CFDA 93.351) to purchase a state-of-the-art small animal PET/CT imaging scanner. This new instrument will serve as a shared resource to support NIH-funded cancer research projects at the university, improving the productivity and scientific quality of studies that seek to better understand cancer biology, radiation therapy effects, and the...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $2,090,971 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to develop and validate a "DEEPTOBIDX" approach for improving breast cancer diagnosis. The key products and services to be delivered include: 1) Engineering a...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $502,841 Project Grant under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program to The Regents of the University of California, operating as Lawrence Berkeley National Laboratory (LBNL). The funding will support research and development of a novel detector readout concept for monolithic scintillation detectors that enables direct digitization...
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to create a new surgical probe prototype for laparoscopic prostate cancer resection procedures. The $161,000 award will fund the development and testing of a probe specifically designed for use with Positron Emission Tomography (PET) radiotracers, which can better...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $553,076 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to the University of Washington. The grant's objective is to develop an advanced computational super-resolution model to enhance the throughput and resolution of chemical imaging techniques, such as stimulated Raman scattering (SRS) microscopy. This research aims to improve...
This Project Grant award, totaling $708,790, was provided by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The grant supports the development and optimization of a modular time-of-flight positron emission tomography (TOF PET) prototype scanner with flexible geometry, based on pixelated LYSO scintillators and novel integrated photosensors. The goal is...
This Project Grant award, valued at $597,766.00, is funded by the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394). The University of Pennsylvania will develop novel methods to image two PET tracers with different molecular targets back-to-back in a single imaging session using a long-axial field-of-view PET scanner, the PennPET Explorer. The key objectives are: Develop protocols to image fluoroglutamine, a research radiotracer of...
The National Cancer Institute (NCI) awarded a $596,095 Project Grant under the Cancer Treatment Research program (CFDA 93.395) to the University of Washington. The grant will support the development and validation of the Personalized Remote Radiation Tracking Portable Organ Dosimetry Device (PRRT PODD), a patient-friendly technology that enables personalization of 177Lu-DOTATATE therapy for neuroendocrine tumor patients. The project aims to design compact imaging detectors and software tools for...
This federal Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower) provides $304,158 to the University of Washington to conduct research on quantitative imaging techniques to characterize tumor heterogeneity in triple negative breast cancer (TNBC). The primary goals are to identify tumor habitat signatures from pre-treatment multiparametric MRI that can help stratify TNBC patients and predict treatment outcomes. The research will involve retrospective...